Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
51.30
-0.35 (-0.68%)
At close: Feb 9, 2026, 4:00 PM EST
51.30
0.00 (0.00%)
After-hours: Feb 9, 2026, 4:10 PM EST
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of $2.94 billion as of February 9, 2026. Its market cap has increased by 37.86% in one year.
Market Cap
2.94B
Enterprise Value
2.69B
1-Year Change
37.86%
Ranking
Category
Stock Price
$51.30
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from $133.80M to $2.94B, an increase of 2,098.44%. That is a compound annual growth rate of 25.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 2.96B | 3.92% |
| Dec 31, 2025 | 2.85B | 42.73% |
| Dec 31, 2024 | 2.00B | 26.29% |
| Dec 29, 2023 | 1.58B | -18.01% |
| Dec 30, 2022 | 1.93B | 24.34% |
| Dec 31, 2021 | 1.55B | 16.99% |
| Dec 31, 2020 | 1.33B | 6.53% |
| Dec 31, 2019 | 1.24B | -28.32% |
| Dec 31, 2018 | 1.74B | -15.02% |
| Dec 29, 2017 | 2.04B | 63.41% |
| Dec 30, 2016 | 1.25B | 90.13% |
| Dec 31, 2015 | 657.50M | 84.54% |
| Dec 31, 2014 | 356.30M | 39.62% |
| Dec 31, 2013 | 255.20M | 45.08% |
| Dec 31, 2012 | 175.90M | 31.46% |
| May 1, 2012 | 133.80M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amneal Pharmaceuticals | 4.56B |
| Lantheus Holdings | 4.30B |
| Kiniksa Pharmaceuticals International, | 3.27B |
| Prestige Consumer Healthcare | 3.14B |
| HUTCHMED (China) | 2.50B |
| Bausch Health Companies | 2.18B |
| Phibro Animal Health | 2.15B |
| Avadel Pharmaceuticals | 2.13B |